Literature DB >> 21217109

High-resolution homozygosity mapping is a powerful tool to detect novel mutations causative of autosomal recessive RP in the Dutch population.

Rob W J Collin1, L Ingeborgh van den Born, B Jeroen Klevering, Marta de Castro-Miró, Karin W Littink, Kentar Arimadyo, Maleeha Azam, Volkan Yazar, Marijke N Zonneveld, Codrut C Paun, Anna M Siemiatkowska, Tim M Strom, Jayne Y Hehir-Kwa, Hester Y Kroes, Jan-Tjeerd H N de Faber, Mary J van Schooneveld, John R Heckenlively, Carel B Hoyng, Anneke I den Hollander, Frans P M Cremers.   

Abstract

PURPOSE: To determine the genetic defects underlying autosomal recessive retinitis pigmentosa (arRP) in the Dutch population and in a subset of patients originating from other countries. The hypothesis was that, because there has been little migration over the past centuries in certain areas of The Netherlands, a significant fraction of Dutch arRP patients carry their genetic defect in the homozygous state.
METHODS: High-resolution genome-wide SNP genotyping on SNP arrays and subsequent homozygosity mapping were performed in a large cohort of 186 mainly nonconsanguineous arRP families living in The Netherlands. Candidate genes residing in homozygous regions were sequenced.
RESULTS: In ~94% of the affected individuals, large homozygous sequences were identified in their genome. In 42 probands, at least one of these homozygous regions contained one of the 26 known arRP genes. Sequence analysis of the corresponding genes in each of these patients revealed 21 mutations and two possible pathogenic changes, 14 of which were novel. All mutations were identified in only a single family, illustrating the genetic diversity within the Dutch population.
CONCLUSIONS: This report demonstrates that homozygosity mapping is a powerful tool for identifying the genetic defect underlying genetically heterogeneous recessive disorders like RP, even in populations with little consanguinity.

Entities:  

Mesh:

Year:  2011        PMID: 21217109     DOI: 10.1167/iovs.10-6185

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  Exome sequencing and cis-regulatory mapping identify mutations in MAK, a gene encoding a regulator of ciliary length, as a cause of retinitis pigmentosa.

Authors:  Rıza Köksal Ozgül; Anna M Siemiatkowska; Didem Yücel; Connie A Myers; Rob W J Collin; Marijke N Zonneveld; Avigail Beryozkin; Eyal Banin; Carel B Hoyng; L Ingeborgh van den Born; Ron Bose; Wei Shen; Dror Sharon; Frans P M Cremers; B Jeroen Klevering; Anneke I den Hollander; Joseph C Corbo
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

2.  Impact of LCA-Associated E14L LRAT Mutation on Protein Stability and Retinoid Homeostasis.

Authors:  Sylwia Chelstowska; Made Airanthi K Widjaja-Adhi; Josie A Silvaroli; Marcin Golczak
Journal:  Biochemistry       Date:  2017-08-15       Impact factor: 3.162

3.  AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs.

Authors:  Virginie Pichard; Nathalie Provost; Alexandra Mendes-Madeira; Lyse Libeau; Philippe Hulin; Kizito-Tshitoko Tshilenge; Marine Biget; Baptiste Ameline; Jack-Yves Deschamps; Michel Weber; Guylène Le Meur; Marie-Anne Colle; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2016-02-09       Impact factor: 11.454

Review 4.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

5.  Mutations in C8orf37, encoding a ciliary protein, are associated with autosomal-recessive retinal dystrophies with early macular involvement.

Authors:  Alejandro Estrada-Cuzcano; Kornelia Neveling; Susanne Kohl; Eyal Banin; Ygal Rotenstreich; Dror Sharon; Tzipora C Falik-Zaccai; Stephanie Hipp; Ronald Roepman; Bernd Wissinger; Stef J F Letteboer; Dorus A Mans; Ellen A W Blokland; Michael P Kwint; Sabine J Gijsen; Ramon A C van Huet; Rob W J Collin; H Scheffer; Joris A Veltman; Eberhart Zrenner; Anneke I den Hollander; B Jeroen Klevering; Frans P M Cremers
Journal:  Am J Hum Genet       Date:  2011-12-15       Impact factor: 11.025

Review 6.  Genomic approaches for the discovery of genes mutated in inherited retinal degeneration.

Authors:  Anna M Siemiatkowska; Rob W J Collin; Anneke I den Hollander; Frans P M Cremers
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

7.  Novel mutations in CRB1 and ABCA4 genes cause Leber congenital amaurosis and Stargardt disease in a Swedish family.

Authors:  Frida Jonsson; Marie S Burstedt; Ola Sandgren; Anna Norberg; Irina Golovleva
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

8.  Genomic patterns of homozygosity in worldwide human populations.

Authors:  Trevor J Pemberton; Devin Absher; Marcus W Feldman; Richard M Myers; Noah A Rosenberg; Jun Z Li
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

9.  Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing.

Authors:  Xia Wang; Hui Wang; Vincent Sun; Han-Fang Tuan; Vafa Keser; Keqing Wang; Huanan Ren; Irma Lopez; Jacques E Zaneveld; Sorath Siddiqui; Stephanie Bowles; Ayesha Khan; Jason Salvo; Samuel G Jacobson; Alessandro Iannaccone; Feng Wang; David Birch; John R Heckenlively; Gerald A Fishman; Elias I Traboulsi; Yumei Li; Dianna Wheaton; Robert K Koenekoop; Rui Chen
Journal:  J Med Genet       Date:  2013-07-11       Impact factor: 6.318

10.  Identification of a novel nonsense mutation in RP1 that causes autosomal recessive retinitis pigmentosa in an Indonesian family.

Authors:  Anna M Siemiatkowska; Galuh D N Astuti; Kentar Arimadyo; Anneke I den Hollander; Sultana M H Faradz; Frans P M Cremers; Rob W J Collin
Journal:  Mol Vis       Date:  2012-10-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.